NEUROPACE INC

NEUROPACE INC

NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts recommend buying NeuroPace's stock with a target price of $19.25, indicating potential growth.

Above Average

Financial Health

NeuroPace is generating strong revenue and cash flow, with healthy profit margins supporting its growth.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Discover More Opportunities

ALGN

ALIGN TECHNOLOGY INC

Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.

AXGN

AXOGEN INC

AxoGen provides products for the peripheral nerve reconstruction and regeneration.

AHCO

ADAPTHEALTH CORP

Provides home medical products direct to consumers and to healthcare providers.

Baskets Featuring NPCE

Wearable Health Stocks: Growth Potential vs Competition

Wearable Health Stocks: Growth Potential vs Competition

Apple's recent FDA clearance for its Apple Watch hypertension feature marks a major step in wearable medical technology. This development opens up investment opportunities in the broader ecosystem of connected health devices and remote patient monitoring services.

Published: September 12, 2025

Explore Basket
Brain-Computer Interface

Brain-Computer Interface

This collection features pioneering companies creating revolutionary pathways between the human brain and machines. These carefully selected stocks represent the cutting edge of neural technology, with potential to transform healthcare and computing through innovative brain signal interpretation.

Published: June 17, 2025

Explore Basket

Why You’ll Want to Watch This Stock

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions